 Methodology article
 Open Access
Algorithms for effective querying of compound graphbased pathway databases
 Ugur Dogrusoz^{1}Email author,
 Ahmet Cetintas^{1},
 Emek Demir^{2} and
 Ozgun Babur^{1}
https://doi.org/10.1186/1471210510376
© Dogrusoz et al; licensee BioMed Central Ltd. 2009
 Received: 2 November 2008
 Accepted: 16 November 2009
 Published: 16 November 2009
Abstract
Background
Graphbased pathway ontologies and databases are widely used to represent data about cellular processes. This representation makes it possible to programmatically integrate cellular networks and to investigate them using the wellunderstood concepts of graph theory in order to predict their structural and dynamic properties. An extension of this graph representation, namely hierarchically structured or compound graphs, in which a member of a biological network may recursively contain a subnetwork of a somehow logically similar group of biological objects, provides many additional benefits for analysis of biological pathways, including reduction of complexity by decomposition into distinct components or modules. In this regard, it is essential to effectively query such integrated large compound networks to extract the subnetworks of interest with the help of efficient algorithms and software tools.
Results
Towards this goal, we developed a querying framework, along with a number of graphtheoretic algorithms from simple neighborhood queries to shortest paths to feedback loops, that is applicable to all sorts of graphbased pathway databases, from PPIs (proteinprotein interactions) to metabolic and signaling pathways. The framework is unique in that it can account for compound or nested structures and ubiquitous entities present in the pathway data. In addition, the queries may be related to each other through "AND" and "OR" operators, and can be recursively organized into a tree, in which the result of one query might be a source and/or target for another, to form more complex queries. The algorithms were implemented within the querying component of a new version of the software tool PATIKA web (Pathway Analysis Tool for Integration and Knowledge Acquisition) and have proven useful for answering a number of biologically significant questions for large graphbased pathway databases.
Conclusion
The PATIKA Project Web site is http://www.patika.org. PATIKA web version 2.1 is available at http://web.patika.org.
Keywords
 Short Path
 Source Node
 Compound Structure
 Homology State
 Pathway Analysis Tool
Background
Especially with the help of novel largescale analysis methods, a massive amount of data is now being gathered on cellular processes [1–3]. Unfortunately, most of these data are fragmented and incomplete. One of the biggest challenges of bioinformatics today is to represent and integrate this type of knowledge effectively to construct a knowledge base that can act as a blueprint for simulations and other analysis methods, enabling us to better understand and predict the behavior of a cell [4].
Even though traditional way of representing cellular pathways with still images often yields very pretty pictures, such drawings are mostly not reusable. In addition, underlying ontology and notation are often far from being uniform or consistent, mostly dependent on implicit conventions rather than explicit, formal rules [4]. Recently, these problems have resulted in a major shift towards the use of more formal ontologies and to the dynamic representation of pathways that support programmatic integration and manipulation of pathways, regardless of the underlying ontology. Among these, graphs, one of the most common discrete mathematical structures [5], have been most popular for "insilico" modeling of biological pathways, from metabolic pathways to gene regulatory networks to signaling pathways [4, 6–8]. Such modeling is crucial for the field of systems biology, which deals with a systemslevel understanding of biological networks. Three levels of increasing complexity are listed in [6] for the analysis of cellular networks, where network topology (global structural properties), interaction patterns (local structural connectivity), and network decomposition (hierarchical functional organization) are addressed at each level, respectively. Representing such complex networks as graphs makes it possible to investigate the topology and function of these networks using the wellunderstood concepts of graph theory and to predict their structural properties or to detect special structures or properties in them. In addition, this representation has made the systematic (i.e., programmatic) integration of these complex networks feasible. A comprehensive survey of such prediction, detection, and reconstruction methods can be found in [6].
Lately, an extension of this graph representation, namely hierarchically structured graphs or simply compound graphs, has become popular, in which a node of a biological network may recursively contain or include a subnetwork of a somehow logically similar group of biological objects [4, 9]. This extension provides many benefits for the analysis of biological pathways; most importantly, it reduces the complexity of large networks by decomposing them into distinct components or modules.
There has been much work on querying for the occurrences of substructures (from specified subgraphs to special substructures), such as graphlets or motifs in graphbased data, including pathways [6]. Most approaches employ a graphmatching algorithm to find one or all (exact or inexact) instances of the specified subgraph [10–12]. Others take a comparative approach to interpreting molecular networks, contrasting and aligning networks of different species and molecular types under varying conditions [13]. Graph algorithms, such as the shortest paths between a specified pair of objects in a graph database, have been in use for quite a while [14], whereas their use in graphbased pathway databases has only recently become popular [15–17].
Definitions
Let G = (V, E) be a graph with a nonempty node set V and an edge set E. An edge, e = {x, y} or simply xy, joining nodes x and y is said to be incident with both x and y. Node x is called a neighbor of y and vice versa. A pathway graph G = (V, E) is a graph, where some of the edges in E are marked as inhibition edges (e.g., an interaction that disables or impedes the target reaction node via the source state node).
A path between two nodes n_{0} and n_{ k }is a nonempty graph P = (V ', E') with V' = {n_{0}, n_{1}, ..., n_{ k }} and E' = {n_{0}n_{1}, n_{1}n_{2} , ..., n_{k1}n_{ k }}, where n_{ i }are all distinct. n_{0} and n_{ k }are called the end points of path P = n_{0}n_{1} ... n_{ k }, whose length, denoted by P is the number of edges on it. A path is said to be directed if all its ordered edges are directed in the same direction. A directed path P is called an incoming (outgoing) path of node n if P ends at target (starts at source) node n. A directed path is called positive (negative) if it contains an even (odd) number of inhibitors (i.e., inhibition edges).
Given node sets A and B, an AB path is a path with its ends in A and B, respectively, and no node of P other than its ends is from either set A or B. An Apath is a path where one of its end nodes is in A, and no other nodes and interactions are from A.
A path C with identical end nodes is called a cycle. A directed cycle is called positive feedback (negative feedback) if it contains an even (odd) number of inhibitors.
Ontology
The query framework and the algorithms described in the paper were all designed and implemented assuming the PATIKA ontology [4], which shows the utmost similarity to standard representations, such as BioPAX [19] and SBGN [20]. However, the results should be applicable to other graphbased pathway representations without difficulty.
More formally, a compound pathway graph CP = (G, I) is a 2tuple of a pathway graph G and a directed acyclic inclusion graph. Notice that this is different than traditional compound graphs as we do not require compound structures in our pathway models to form a tree. I, where

V (G): union of nodes denoting bioentities, states, transitions, molecular complexes, and abstractions of five distinct types: regular, incomplete state, incomplete transition, homology state, and homology transition;

E(G): union of interaction edges of various types (such as PPI edges at bioentity level and activator edges between a state and a transition), some of which are directed and/or inhibitory;

V (I) = V (G);

E(I): union of inclusion edges for defining compound structures (molecular complexes and abstractions).
In order for a compound pathway graph CP = (G, I) to comply with the PATIKA ontology, it needs to satisfy certain additional invariants; for instance, regular abstractions cannot have a direct interaction (edge).
Results
PATIKA web[18] is a pathway analysis tool with a distributed architecture, where the server is composed of a database component and an application server. The implementation uses the JSP (JavaServer Pages) edition of the Tom Sawyer Visualization technology [21] to handle highlydynamic and advanced visual content along with Java™, JavaScript™ and DHTML/HTML.
The query component of PATIKA web was implemented as a Java applet, embracing all algorithms discussed in this paper. See Additional file 1 for a sample querying scenario comprised of a number of these operations.
Query interface of PATIKAweb
Experiments
We performed a number of experiments to test our algorithms using the implementation within PATIKA web. The tests were performed on an ordinary personal computer using a randomly created integrated pathway knowledge base, consisting of about 20,000 pathway nodes and 30,000 edges. The knowledge base was held in memory. However, with the success of current high performance object/relational persistence and query services, the slowdown should not be dramatic when it is on disk. Our experiments revealed that our theoretical analysis is in line with the results of our implementation. Below, we provide the details.
Experiments in this set also measure k versus the execution time with random source sets of various sizes. As Figure 6 illustrates, independent of the source set size, execution time increases rapidly (but not exponentially) up to a certain distance (between 12 and 15), after which it remains constant. One might expect an exponential increase in the number of nodes reached (and thus, the execution time) as the distance increases. However, in practice, up to all of the neighbors of a newly visited node might already have been visited, avoiding a combinatorial increase [22]. After a certain number of steps, all nodes are expected to have been visited.
Another set of experiments we performed was to compute the shortest paths SP(S, T, k, d). Remember that the time complexity of this algorithm is O(l + NB(S, k)), where l is the total length of the paths enumerated. Here, l depends on the choice of S and T, and can be exponential in the size of the graph, in the worst case. However, our experiments show that, on average, that is not the case, and l is dominated by the second term. The reason for this is that, roughly speaking, if the shortest length between sets is "too long", the number of paths found is small. Similarly, if the number of paths found is large, the shortest length between sets is short. Obviously, l equals the number of paths found multiplied by the shortest path length between sets. Therefore, there is a tradeoff between the number of paths and the shortest length between sets. This hides the exponential behavior expected in the worst case. Figure 6 plots the shortest path length versus the execution time for the shortest path algorithm, where node sets S and T of varying sizes (chosen from set {1, 3, 5, 10, 15, 20, 25, 50}) were picked randomly. The details of this analysis may be found in Additional file 2.
Discussion
Imagine a researcher who observes a certain gene's expression level oscillating in a manner that can be best described with a feedback loop. Figuring out which molecular interactions caused this behavior might require a review of many research articles and the integration of information across various sources. A review article or a pathway diagram can be immensely helpful, but only if it completely contains the path in question. In the case of a single gene, this analysis is timeconsuming and painstaking. When using highthroughput data, for which one needs to consider multiple entities in a much broader scope, it becomes virtually impossible.
To face this challenge, hundreds of pathway databases were developed [23], and efforts to form an integrated map of cellular events are underway [24]. However, we also need to be able to automatically construct "pathways" by extracting relevant portions of the underlying network, based on the biological question we are asking. Compared to static pathway diagrams, such "dynamic" queries can provide a more complete picture, and can help manage complexity by removing portions that are not of interest. The algorithms and framework presented here provide such facilities for an elementary set of biological questions.
One can extend this basic set by adding algorithms that perform advanced queries, such as flux balance analysis [25], isomorphic graph matching [6], and differential expression analysis [26]. To complement advances in pathway databases and tools, we expect algorithms such as these to become commonplace in biological research. Towards this goal, we hope to make this framework and basic set of operations available as a public library, ready to accept pathway models in standard formats such as BioPAX.
Methods
We first explain how certain special pathway structures, namely compound structures and ubiquitous entities, are to be handled. Then, we define a number of graphtheoretic problems along with associated algorithms.
Compound structures
All the query operations described later, make use of traversals over a pathway knowledge base to compute the desired subgraph of interest. The traversal over pathway objects represented by some sort of a compound structure (e.g., regular abstractions or molecular complexes as defined by the PATIKA ontology) calls for a special mechanism. Take as an example a breadthfirst traversal, starting with node n_{3} over the compound graph in Figure 2. When the traversal reaches the compound node c_{1}, should it also visit its member nodes n_{4} and n_{5}? Or if it reaches its member n_{5}, should it also visit its sibling n_{4}, and continue its downstream towards n_{1}?
The answer depends on the context. If an underlying "equivalence relation" exists between a compound node and its members, a traversal reaching a node in an equivalence set should also reach and visit other nodes in this set. For instance, when a traversal reaches a gene that is a member of a homology abstraction (i.e., it is inside a compound structure along with its homologous genes), it should also be considered to have reached its siblings (i.e., its homologous genes). On the other hand, reaching a member of a regular abstraction should rarely be interpreted as reaching all the other members of that abstraction. Thus, it is best to let the user decide how the traversals over compound structures should be configured for each type of such structures.
This problem may be addressed by using traversal options that define how the traversal continues upon reaching a compound structure or a member of the compound structure. Note, however, that we need two flags per type of compound structure, as they might be set to be different:

Link a compound structure and its members: For instance, should reaching a homology state be interpreted as also reaching its members (i.e., the genes that are homologous) and vice versa?

Link members of a compound structure: For instance, should reaching a member of a molecular complex be interpreted as reaching all members of this complex (thus the traversal should be able to continue from other members as in Figure 7)?
For the ontology that we assume, there are six distinct types of compound structures: five types of abstractions (homology states and transitions, incomplete states and transitions, and regular abstractions) and molecular complexes. Once such a set of options is defined, the modification needed in a query algorithm to support compound structures is rather straightforward. When a compound node or a member of a compound is visited during a traversal, the algorithm forms a set of "equivalent" nodes, and continues the traversal from these equivalent nodes as well as from the visited node. In other words, the algorithm acts as if it's not only this node that is a neighbor of the previously visited node but also its equivalent nodes.
More formally, node x is called equivalent for traversal with node y if and only if

x and y are members of the same compound node, and the user defined flag for linking members of this type of compound structure is true, or

one is a compound and parent node (possibly an indirect parent through multiple levels of nesting) of the other, and the user defined flag for linking this type of compound structure and its members is true.
Notice that equivalence for traversal is a binary relationship that is not transitive.
Edges outside E do not count towards the length of compound paths.
For instance, a breadthfirst traversal over a compound graph can be sketched as follows:
 1
Q := {root}
 2
while Q ≠ ∅ do
 3
n _{1} := Q. DEQUEUE()
 4
N := n _{1}. COMPOUND NEIGHBORS()
 5
for n _{2} ∈ N do
 6
if n _{2}.VISITED ≠ true then
 7
Q.ENQUEUE(n _{2})
 8
8 //process n_{1}
 9
n _{1}.VISITED := true
The only difference from the regular breadthfirst traversal, here, is line 4. The neighbors of the currently processed node n_{1} are identified not only based on the downstream nodes of n_{1}, but also on the nodes equivalent to these downstream nodes with respect to compound structures. This simple difference makes it easier to modify existing graphtheoretic algorithms to add support for compound structures.
Ubiquitous entities
Another type of biological object that requires special attention is ubiquitous molecules, which typically participate in many different biological activities, have relatively constant concentration and do not transmit a signal. For instance, a ubiquitous molecule such as ATP might be involved in hundreds if not thousands of reactions at the mechanistic level. Thus, one might prefer not to link two reactions whose only common actors are these kinds of molecules. Therefore, traversal over ubiquitous molecules should also be able to be controlled by customized options. Figure 7 explains this with an example. Modification needed in graph algorithms to handle ubiquitous molecules is rather straightforward.
Algorithms
A careful requirements analysis has yielded the following graphtheoretic problems and associated algorithms that might be useful in querying cellular pathway databases. This list is by no means exhaustive and can easily be extended. Unless otherwise stated, all algorithms have both directed and undirected versions.
Neighborhood of entities
Upstream or downstream of entities
 1
v.AVAILABLE := false
 2
if length < maxLength then
 3
for w ∈ v.COMPOUND NEIGHBORS(dir) do
 4
if w is an inhibitor then sign := sign //change sign of running path
 5
if sign = desiredSign then R := R ∪ {w}
 6
else A := A ∪ {w}
 7
if w.AVAILABLE = true then //prevents infinite loop
 8
STREAM(v, length + 1, maxLength, sign, desiredSign, dir)
 9
v.AVAILABLE:= true
 10
return R, A
The algorithm performs a bruteforce traversing of all the nodes in the kneighborhood of the source node. It is based on a depthfirst search. However, after the recursive processing of a node finishes, that node is marked as "unvisited" again, potentially leading to multiple visits of nodes and edges. More specifically, every node and edge is processed as many times as the number of distinct ways they can be reached from the source node. In other words, every possible compound path with a length limit from the source node is examined to determine if it makes a valid stream.
Naturally, the worstcase time complexity of this algorithm is exponential in the size of the kneighborhood of the source node. Experiments show, however, that the execution time should be acceptable for most interactive applications for small values of k (for instance, up to 10).
Common targets or regulators
There are already a number of algorithms for inferring highly connected or coregulated subnetworks of cellular interactions and processes often called modules or pathways [30–32]. When analyzing these modules, we often want to know if there is a process or gene that is upstream of the genes in the module, which can provide a causal explanation for the coregulation, and ultimately a way to control the module. Similarly, two pathways affecting the same mechanism in the cell is interesting since it suggests that a specific phenotype can have more than one molecular cause. For instance, Engelman et al. [33] discuss that drug resistance in lung cancer is related to an alternative pathway that leads to PI3K activation. Searching for common targets of signaling proteins can help to develop alternative treatment strategies.
 1
C := R:= ∅ //candidate and result sets, respectively
 2
for n _{1} ∈ S do
 3
C := C ∪ CUCOMPOUND BFS(n _{1}, k, dir)
 4
for n _{2} ∈ C do
 5
if n 2.LABEL(reached) = S then R := R ∪ {n _{2}}
 6
return R
This operation takes O(S·NB(S, k)) time, as a BFS is performed for each node in S.
In addition, one might require such paths leading to potential targets or originating from potential regulators to be positive or negative. For instance, the common downstream of source nodes S reached by positive compound paths of length up to k only, denoted by CD^{+}(S, k), might be of interest. However, we conjecture that the complexity of such an operation is asymptotically higher.
Network of interest
A problem that arises frequently in highthroughput studies is gene/protein selection. For example, new highthroughput sequencing technologies enabled scanning for mutations in a large number of samples. With the current technology, the feasible number of genes that can be sequenced is in the order of tens to hundreds [34]. One way to select new genes for sequencing is to search within the vicinity of the genes that are already implied in that cancer. Particularly, genes that connect one or more of these usual suspects via a signaling path are more likely to be critical for the disease.
The following algorithm can handle directed compound pathways. It could, however, be simplified for undirected pathways by removing a redundant call to GO ICOMPOUND BFS.
 1
C := GO ICOMPOUND BFS(S, k, fwd) ∪ GO ICOMPOUND BFS(S, k, rev)
 2
for q ∈ C do
 3
if q.LABEL(fwd) + q.LABEL(rev) ≤ k then R := R ∪ {q}
 4
R := PURIFY(S, R)
 5
return R
 1
Add all the nodes in set S to queue Q
 2
Initialize dir labels of all the nodes in S to zero
 3
T:= ∅
 4
while Q ≠ ∅ do
 5
n _{1} := Q.DEQUEUE()
 6
for e ∈ n _{1}.INCIDENT EDGES(dir) do
 7
if dir = fwd then e.LABEL(dir):= n _{1}.LABEL(dir) +1
 8
else e.LABEL(dir):= n _{1}.LABEL(dir)
 9
for n _{2} ∈ e.COMPOUND OTHER END(n _{1}) do
 10
T := T ∪ {e, n _{2}}
 11
if n _{2}.LABEL(dir) > n _{1}.LABEL(dir) +1 then
 12
n _{2}.LABEL(dir) := n _{1}.LABEL(dir) +1
 13
if n _{2}.LABEL(dir) < k and n _{2} ∉ S then Q.ENQUEUE(n _{2})
 14
return T
The complexity of this operation is clearly O(NB(S, k)); that is, linear in the number of nodes and edges in the kneighborhood of nodes of interest.
Shortest paths between entities
 1
R := SPCOMPOUND BFS(S, T, k, d, mod)
 2
return BUILD UP AND ENUM PATHS(S, T, R)
 1
for n ∈ R do
 2
Construct a new path p for n
 3
Add all nodes in set R to queue Q
 4
W:= ∅
 5
while Q ≠ ∅ do
 6
n _{1} := Q.DEQUEUE()
 7
for n _{2} ∈ n _{1}.COMPOUND NEIGHBORS(mod) do
 8
if n _{2}.LABEL() = n _{1}.LABEL()1 then
 9
W := W ∪ {(n _{1}, n _{2}) }
 10
if n _{2} ∉ W and n _{2}.LABEL() ≠ 0 then
 11
W := W ∪ {n _{2}}
 12
Q.ENQUEUE(n _{2})
 13
if n _{2} is the first neighbor then Concatenate n _{2} to paths of n _{1}
 14
else Clone all the paths of n _{1} and add them to paths of n _{2}
 15
Update path list of n _{2}
 16
Update sign of paths of n _{2} with edge (n _{1}, n _{2})
 17
return W, paths
Here, SPCOMPOUND BFS runs a BFS, starting with nodes in set S in provided mod, up to maximum depth k or shortest compound path length plus d, whichever is smaller, and returns the reached nodes in T while labeling each node with its distance from source. The overall complexity of the algorithm is O(l + NB(S, k)), where l is the total length of the paths enumerated. Here, l can be exponential in the size of the graph, in the worst case. Notice that the above algorithm enumerates all shortest compound paths. If it suffces to find all the nodes and edges on such paths, rather than listing individual paths, BUILD UP AND ENUM PATHS may be simplified, resulting in a theoretically faster operation.
Feedback of an entity
Inferring causal relationships between biological entities [36, 37] is both critically important and difficult. One problem stems from feedback loops abundant in biological systems. When analyzing the results of these algorithms or methods, one often wants to check if there exists a known feedback loop to flag the inferences that are potentially false.
The algorithm starts at source s, and builds a directed path sn_{1}n_{2}n_{3}⋯n_{ k }in a depthfirst manner. A cycle is found if the next vertex n_{k+1}equals s. After generating this cycle, the next edge going out of n_{ k }is explored. If all edges going out from n_{ k }have been explored or the maximum length is exceeded, the algorithm backs up to the previous vertex n_{k1}, and continues. This process continues until we try to back up past the source node s. At that point, all cycles involving s have been discovered, so s can be removed from the graph, and the process can be repeated until the source set becomes empty.
To prevent traversing cycles originating at a vertex n_{ i }during the search rooted at s, all vertices on the current path are marked as "unavailable" extensions of that path. For this, a flag is maintained, which is set to false as soon as n is appended to the current path. That node will remain unavailable until the algorithm backs up past n to its previous vertex on the graph. If the current path up to n does not lead to a cycle, it will remain unavailable, even if the algorithm backs up past it. This prevents redundant deadend searches. Vertex n will, however, be marked available if a cycle could not be found due to cycle length limit, because it is possible for a shorter path to form a cycle by going through n.
Similar to the basis operation given in [38], this algorithm is of O(NB(S, k)·(c + 1)) time complexity, where c is the total number of cycles (positive and negative) discovered.
Declarations
Acknowledgements
The authors thank the rest of the Patikans (especially S. Tekin and H. Kucuk) for their contributions. This work was supported in part by TUBITAK (grant 104E049).
Authors’ Affiliations
References
 Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B, Kanapin A, Lewis S, Mahajan S, May B, Schmidt E, Vastrik I, Wu G, Birney E, Stein L, D'Eustachio P: Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res 2009, (37 Database):D619–22. 10.1093/nar/gkn863Google Scholar
 Caspi R, Foerster H, Fulcher CA, Kaipa P, Krummenacker M, Latendresse M, Paley S, Rhee SY, Shearer AG, Tissier C, Walk TC, Zhang P, Karp PD: The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res 2008, (36 Database):D623–31.Google Scholar
 Okuda S, Yamada T, Hamajima M, Itoh M, Katayama T, Bork P, Goto S, Kanehisa M: KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res 2008, (36 Web Server):W423–6. 10.1093/nar/gkn282Google Scholar
 Demir E, Babur O, Dogrusoz U, Gursoy A, Ayaz A, Gulesir G, Nisanci G, CetinAtalay R: An Ontology for Collaborative Construction and Analysis of Cellular Pathways. Bioinformatics 2004, 20(3):349–356. 10.1093/bioinformatics/btg416View ArticlePubMedGoogle Scholar
 Bondy JA, Murty USR: Graph Theory with Applications. Great Britain: The McMillan Press Ltd; 1976.View ArticleGoogle Scholar
 Aittokallio T, Schwikowski B: Graphbased methods for analysing networks in cell biology. Briefings in Bioinformatics 2006, 7(3):243–255. 10.1093/bib/bbl022View ArticlePubMedGoogle Scholar
 Reddy VN, Mavrovouniotis ML, Liebman MN: Petri Net Representations in Metabolic Pathways. 1st International Conference on Intelligent Systems for Molecular Biology 1993, 328–336.Google Scholar
 Hofestädt R, Thelen S: Qualitative modeling of biochemical networks. In Silico Biology 1998, 1: 39–53.PubMedGoogle Scholar
 Fukuda K, Takagi T: Knowledge representation of signal transduction pathways. Bioinformatics 2001, 17(9):829–837. 10.1093/bioinformatics/17.9.829View ArticlePubMedGoogle Scholar
 Tian Y, McEachin RC, Santos C, States DJ, Patel JM: SAGA: a subgraph matching tool for biological graphs. Bioinformatics 2007, 23(2):232–239. 10.1093/bioinformatics/btl571View ArticlePubMedGoogle Scholar
 Yip KY, Yu H, Kim PM, Schultz M, Gerstein M: The tYNA platform for comparative interactomics: a web tool for managing, comparing and mining multiple networks. Bioinformatics 2006, 22(23):2968–2970. 10.1093/bioinformatics/btl488View ArticlePubMedGoogle Scholar
 Shlomi T, Segal D, Ruppin E, Sharan R: QPath: a method for querying pathways in a proteinprotein interaction network. BMC Bioinformatics 2006, 7: 199. 10.1186/147121057199PubMed CentralView ArticlePubMedGoogle Scholar
 Sharan R, Ideker T: Modeling cellular machinery through biological network comparison. Nature Biotechnology 2006, 24(4):427–433. 10.1038/nbt1196View ArticlePubMedGoogle Scholar
 Gting R: GraphDB: Modeling and Querying Graphs in Databases. Proc 20th Int Conf on Very Large Databases, Santiago, Chile 1994, 297–308. [http://portal.acm.org/citation.cfm?id=672980]Google Scholar
 Leser U: A query language for biological networks. Bioinformatics 2005, 21(2):33–39. 10.1093/bioinformatics/bti1105Google Scholar
 Croes D, Couche F, Wodak SJ, van Helden J: Metabolic PathFinding: inferring relevant pathways in biochemical networks. Nucleic Acids Research 2005, 33: W326. 10.1093/nar/gki437PubMed CentralView ArticlePubMedGoogle Scholar
 Baitaluk M, Sedova M, Ray A, Gupta A: BiologicalNetworks: visualization and analysis tool for systems biology. Nucleic Acids Research 2006, (34 WebServer):466–471. 10.1093/nar/gkl308Google Scholar
 Dogrusoz U, Erson E, Giral E, Demir E, Babur O, Cetintas A, Colak R: P ATIKA web: a Web interface for analyzing biological pathways through advanced querying and visualization. Bioinformatics 2006, 22(3):374–375. 10.1093/bioinformatics/bti776View ArticlePubMedGoogle Scholar
 BioPAX: Biological Pathways Exchange.2007. [http://www.biopax.org]Google Scholar
 SBGN: Systems Biology Graphical Notation.2007. [http://www.sbgn.org]Google Scholar
 Dogrusoz U, Feng Q, Madden B, Doorley M, Frick A: Graph Visualization Toolkits. IEEE Computer Graphics and Applications 2002, 22: 30–37. 10.1109/38.974516View ArticleGoogle Scholar
 Barabasi AL, Oltvai ZN: Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5(2):101–113. [http://dx.doi.org/10.1038/nrg1272] 10.1038/nrg1272View ArticlePubMedGoogle Scholar
 Bader G, Cary M, Sander C: Pathguide: a pathway resource list. Nucleic Acids Research 2006, (34 Database):D504–6. 10.1093/nar/gkj126Google Scholar
 Pathway Commons: Pathway Commons.2007. [http://www.pathwaycommons.org]Google Scholar
 Bonarius HPJ, Schmid G, Tramper J: Flux analysis of underdetermined metabolic networks: The quest for the missing constraints. Trends in Biotechnology 1997, 15: 308–314. 10.1016/S01677799(97)010676View ArticleGoogle Scholar
 Babur O, Demir E, Ayaz A, Dogrusoz U, Sakarya O: Microarray Data Analysis and Pathway Activity Inference in PATIKA. 2004.Google Scholar
 Yeung N, Cline MS, Kuchinsky A, Smoot ME, Bader GD: Exploring biological networks with Cytoscape software. Curr Protoc Bioinformatics 2008., Chapter 8(Unit 8.13):Google Scholar
 Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, Kitano H: CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks. Proceedings of the IEEE 2008, 96(8):1254–1265. 10.1109/JPROC.2008.925458View ArticleGoogle Scholar
 Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A, Banerjee S, Somanathan DS, Sebastian A, Rani S, Ray S, Harrys Kishore CJ, Kanth S, Ahmed M, Kashyap MK, Mohmood R, Ramachandra YL, Krishna V, Rahiman BA, Mohan S, Ranganathan P, Ramabadran S, Chaerkady R, Pandey A: Human Protein Reference Database2009 update. Nucleic Acids Res 2009, 37: D767–772. 10.1093/nar/gkn892PubMed CentralView ArticlePubMedGoogle Scholar
 Brohe S, van Helden J: Evaluation of clustering algorithms for proteinprotein interaction networks. BMC Bioinformatics 2006, 7: 488. 10.1186/147121057488View ArticleGoogle Scholar
 Wong DJ, Nuyten DS, Regev A, Lin M, Adler AS, Segal E, Vijver MJ, Chang HY: Revealing targeted therapy for human cancer by gene module maps. Cancer Res 2008, 68: 369–378. 10.1158/00085472.CAN070382View ArticlePubMedGoogle Scholar
 Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA, Marks JR, Dressman HK, West M, Nevins JR: Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006, 439: 353–357. 10.1038/nature04296View ArticlePubMedGoogle Scholar
 Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Jnne PA: MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007, 316: 1039–1043. 10.1126/science.1141478View ArticlePubMedGoogle Scholar
 The Cancer Genome Atlas Research Network: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455: 1061–1068. 10.1038/nature07385View ArticleGoogle Scholar
 Cormen TH, Leiserson CE, Rivest RL: Introduction to Algorithms. Cambridge: McGrawHill; 1985.Google Scholar
 Wang K, Alvarez MJ, Bisikirska BC, Linding R, Basso K, Dalla Favera R, Califano A: Dissecting the interface between signaling and transcriptional regulation in human B cells. Pac Symp Biocomput 2009, 20: 264–275.Google Scholar
 Danos V, Feret J, Fontana W, Harmer R, Krivine J: Rulebased modelling of cellular signalling. In CONCUR'07. Springer Berlin; 2007:17–41.Google Scholar
 Reingold EM, Nievergelt J, Deo N: Combinatorial Algorithms: Theory and Practice. Englewood Cliffs, NJ: PrenticeHall; 1977.Google Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.